Maternal early-pregnancy thyroid function is associated with subsequent hypertensive disorders of pregnancy: The generation R study

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 12, 2014, Pages E2591-E2598

  Medici, Marco ^a   Korevaar, Tim I M ^a   Schalekamp Timmermans, Sarah ^a,b   Gaillard, Romy ^a,b   De Rijke, Yolanda B ^a,b   Visser, W Edward ^a   Visser, Willy ^b   De Muinck Keizer Schrama, Sabine M P F ^b   Hofman, Albert ^a   Hooijkaas, Herbert ^a   Bongers Schokking, Jacoba J ^b   Tiemeier, Henning ^b   Jaddoe, Vincent W V ^a,b   Visser, Theo J ^a   Peeters, Robin P ^a   Steegers, Eric A P ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE; IODINE;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; DISEASE ASSOCIATION; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PREECLAMPSIA; PREGNANCY; RISK ASSESSMENT; THYROID DISEASE; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; AUTOIMMUNE THYROIDITIS; BLOOD; BLOOD PRESSURE; COHORT ANALYSIS; COMPLICATION; PATHOPHYSIOLOGY; PHYSIOLOGY; THYROID FUNCTION TEST; THYROID GLAND; URINE;

ADULT; BLOOD PRESSURE; COHORT STUDIES; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; IODINE; PREGNANCY; PREGNANCY TRIMESTER, FIRST; RISK ASSESSMENT; THYROID DISEASES; THYROID FUNCTION TESTS; THYROID GLAND; THYROIDITIS, AUTOIMMUNE;

EID: 84916597748     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-1505     Document Type: Article

References (40)

1. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33:130-137.
2. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367:1066-1074.
3. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376:631-644.
4. Burggraaf J, Lalezari S, Emeis JJ, et al. Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol. Thyroid. 2001;11:153-160.
5. Cesareo R, Tarabuso A, Di Benedetto M, Lacerna F, Reda G. Plasmatic endothelin-1 levels in hyperthyroid patients before and after antithyroid therapy. Minerva Endocrinol. 2000;25:1-3.
6. Danzi S, Klein I. Thyroid hormone and blood pressure regulation. Curr Hypertens Rep. 2003;5:513-520.
7. De Ciuceis C, Pilu A, Cappelli C, et al. Decreased number of circulating endothelial progenitor cells in patients with Graves' hyperthyroidism. J Endocrinol Invest. 2011;34:335-339.
8. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;344:501-509.
9. Ashoor G, Maiz N, Rotas M, Kametas NA, Nicolaides KH. Maternal thyroid function at 11 to 13 weeks of gestation and subsequent development of preeclampsia. Prenat Diagn. 2010;30:1032-1038.
10. Casey BM, Dashe JS, Wells CE, et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol. 2005;105:239-245.
11. Cleary-Goldman J, Malone FD, Lambert-Messerlian G, et al. Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol. 2008;112:85-92.
12. Karakosta P, Alegakis D, Georgiou V, et al. Thyroid dysfunction and autoantibodies in early pregnancy are associated with increased risk of gestational diabetes and adverse birth outcomes. J Clin Endocrinol Metab. 2012;97:4464-4472.
13. Leung AS, Millar LK, Koonings PP, Montoro M, Mestman JH. Perinatal outcome in hypothyroid pregnancies. Obstet Gynecol. 1993;81:349-353.
14. Luewan S, Chakkabut P, Tongsong T. Outcomes of pregnancy complicated with hyperthyroidism: a cohort study. Arch Gynecol Obstet. 2011;283:243-247.
15. Mannisto T, Mendola P, Grewal J, Xie Y, Chen Z, Laughon SK. Thyroid diseases and adverse pregnancy outcomes in a contemporary US cohort. J Clin Endocrinol Metab. 2013;98:2725-2733.
16. Mannisto T, Vaarasmaki M, Pouta A, et al. Thyroid dysfunction and autoantibodies during pregnancy as predictive factors of pregnancy complications and maternal morbidity in later life. J Clin Endocrinol Metab. 2010;95:1084-1094.
17. Millar LK, Wing DA, Leung AS, Koonings PP, Montoro MN, Mestman JH. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol. 1994;84:946-949.
18. Sahu MT, Das V, Mittal S, Agarwal A, Sahu M. Overt and subclinical thyroid dysfunction among Indian pregnant women and its effect on maternal and fetal outcome. Arch Gynecol Obstet. 2010;281:215-220.
19. Wilson KL, Casey BM, McIntire DD, Halvorson LM, Cunningham FG. Subclinical thyroid disease and the incidence of hypertension in pregnancy. Obstet Gynecol. 2012;119:315-320.
20. Medici M, Timmermans S, Visser W, et al. Maternal thyroid hormone parameters during early pregnancy and birth weight: the Generation R Study. J Clin Endocrinol Metab. 2013;98:59-66.
21. Shields BM, Knight BA, Hill A, Hattersley AT, Vaidya B. Fetal thyroid hormone level at birth is associated with fetal growth. J Clin Endocrinol Metab. 2011;96:E934-E938.
22. Taylor PN, Razvi S, Pearce SH, Dayan C. A review of the clinical consequences of variation in thyroid function within the reference range. J Clin Endocrinol Metab. 2013;98:3562-3571.
23. Jaddoe VW, van Duijn CM, Franco OH, et al. The Generation R Study: design and cohort update 2012. Eur J Epidemiol. 2012;27:739-756.
24. Medici M, de Rijke YB, Peeters RP, et al. Maternal early pregnancy and newborn thyroid hormone parameters: the GenerationRstudy. J Clin Endocrinol Metab. 2012;97:646-652.
25. Medici M, Ghassabian A, Visser W, et al. Women with high early pregnancy urinary iodine levels have an increased risk of hyperthyroid newborns: the population-based Generation R Study. Clin Endocrinol (Oxf). 2013;80(4):598-606.
26. World Health Organization United Nations Children's Fund, International Council for the Control of Iodine Deficiency Disorders. Assessment of Iodine Deficiency Disorders and Monitoring Their Elimination. 3rd ed. Geneva: World Health Organization; 2007.
27. Bakker R, Steegers EA, Mackenbach JP, Hofman A, Jaddoe VW. Maternal smoking and blood pressure in different trimesters of pregnancy: the Generation R study. J Hypertens. 2010;28:2210-2218.
28. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001;20:IX-XIV.
29. Coolman M, de Groot CJ, Jaddoe VW, Hofman A, Raat H, Steegers EA. Medical record validation of maternally reported history of preeclampsia. J Clin Epidemiol. 2010;63:932-937.
30. Goldstein H. Multilevel Statistical Methods. 2nd ed. London: Edward Arnold; 1995.
31. Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol. 1999;28:964-974.
32. Lambert-Messerlian G, McClain M, Haddow JE, et al. FaSTER Research Consortium. First- and second-trimester thyroid hormone reference data in pregnant women: a FaSTER (First- and Second-Trimester Evaluation of Risk for aneuploidy) Research Consortium study. Am J Obstet Gynecol. 2008;199:62.e1-e6.
33. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335:974.
34. Vikse BE, Irgens LM, Leivestad T, Skjaerven R, Iversen BM. Preeclampsia and the risk of end-stage renal disease. N Engl J Med. 2008;359:800-809.
35. Williams D. Long-term complications of preeclampsia. Semin Nephrol. 2011;31:111-122.
36. Heikura U, Hartikainen AL, Nordstrom T, Pouta A, Taanila A, Jarvelin MR. Maternal hypertensive disorders during pregnancy and mild cognitive limitations in the offspring. Paediatr Perinat Epidemiol. 2013;27:188-198.
37. Tenhola S, Rahiala E, Halonen P, Vanninen E, Voutilainen R. Maternal preeclampsia predicts elevated blood pressure in 12-year-old children: evaluation by ambulatory blood pressure monitoring. Pediatr Res. 2006;59:320-324.
38. van Wassenaer AG, Westera J, van Schie PE, et al. Outcome at 4.5 years of children born after expectant management of early-onset hypertensive disorders of pregnancy. Am J Obstet Gynecol. 2011; 204:510.
39. Li Y, Chen H, Tan J, Wang X, Liang H, Sun X. Impaired release of tissue plasminogen activator from the endothelium in Graves' disease - indicator of endothelial dysfunction and reduced fibrinolytic capacity. Eur J Clin Invest. 1998;28:1050-1054.
40. Poon LC, Kametas NA, Maiz N, Akolekar R, Nicolaides KH. Firsttrimester prediction of hypertensive disorders in pregnancy. Hypertension. 2009;53:812-818.